ReP USP - Resultado da busca

Artigo de periodico
Cardiovascular disease onset in old people with severe hypercholesterolemia (2023)
Coutinho, Elaine R; Miname, Marcio H; Rocha, Viviane Z; Bittencourt, Marcio S; Jannes, Cinthia E; Krieger, Jose Eduardo ; Pereira, Alexandre C; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, FATORES DE RISCO, ARTERIOSCLEROSE, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, Elaine R et al. Cardiovascular disease onset in old people with severe hypercholesterolemia. Atherosclerosis, v. 365, p. 9-14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52911. Acesso em: 24 maio 2024.
APA
Coutinho, E. R., Miname, M. H., Rocha, V. Z., Bittencourt, M. S., Jannes, C. E., Krieger, J. E., et al. (2023). Cardiovascular disease onset in old people with severe hypercholesterolemia. Atherosclerosis, 365, 9-14. doi:10.1016/j.atherosclerosis.2022.12.007
NLM
Coutinho ER, Miname MH, Rocha VZ, Bittencourt MS, Jannes CE, Krieger JE, Pereira AC, Santos Filho RD dos. Cardiovascular disease onset in old people with severe hypercholesterolemia [Internet]. Atherosclerosis. 2023 ; 365 9-14.[citado 2024 maio 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52911
Vancouver
Coutinho ER, Miname MH, Rocha VZ, Bittencourt MS, Jannes CE, Krieger JE, Pereira AC, Santos Filho RD dos. Cardiovascular disease onset in old people with severe hypercholesterolemia [Internet]. Atherosclerosis. 2023 ; 365 9-14.[citado 2024 maio 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52911
Artigo de periodico
The fungicide Tebuconazole induces electromechanical cardiotoxicity in murine heart and human cardiomyocytes derived from induced pluripotent stem cells (2022)
Santos-Miranda, Artur; Joviano-Santos, V. Julliane; Cruz-Nascimento, Taynara; Neri, Elida Adalgisa; Souza, Diego Santos; Marques, Leisiane Pereira; Krieger, Jose Eduardo ; Roman-Campos, Danilo
Source: Toxicology letters. Unidade: FM
Subjects: ARRITMIA, POTENCIAIS DE AÇÃO, CÉLULAS-TRONCO, FUNGICIDAS INDUSTRIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS-MIRANDA, Artur et al. The fungicide Tebuconazole induces electromechanical cardiotoxicity in murine heart and human cardiomyocytes derived from induced pluripotent stem cells. Toxicology letters, v. 359, p. 96-105, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.toxlet.2022.02.005. Acesso em: 24 maio 2024.
APA
Santos-Miranda, A., Joviano-Santos, V. J., Cruz-Nascimento, T., Neri, E. A., Souza, D. S., Marques, L. P., et al. (2022). The fungicide Tebuconazole induces electromechanical cardiotoxicity in murine heart and human cardiomyocytes derived from induced pluripotent stem cells. Toxicology letters, 359, 96-105. doi:10.1016/j.toxlet.2022.02.005
NLM
Santos-Miranda A, Joviano-Santos VJ, Cruz-Nascimento T, Neri EA, Souza DS, Marques LP, Krieger JE, Roman-Campos D. The fungicide Tebuconazole induces electromechanical cardiotoxicity in murine heart and human cardiomyocytes derived from induced pluripotent stem cells [Internet]. Toxicology letters. 2022 ; 359 96-105.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.toxlet.2022.02.005
Vancouver
Santos-Miranda A, Joviano-Santos VJ, Cruz-Nascimento T, Neri EA, Souza DS, Marques LP, Krieger JE, Roman-Campos D. The fungicide Tebuconazole induces electromechanical cardiotoxicity in murine heart and human cardiomyocytes derived from induced pluripotent stem cells [Internet]. Toxicology letters. 2022 ; 359 96-105.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.toxlet.2022.02.005
Artigo de periodico
Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk (2021)
Ma, Feng; Darabi, Maryam; Lhomme, Marie; Tubeuf, Emilie; Canicio, Aurelie; Brerault, Jean; Medadje, Narcisse; Rached, Fabiana; Serrano Junior, Carlos Vicente ; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: LIPOPROTEÍNAS HDL, COLESTEROL, FATORES DE RISCO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MA, Feng et al. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, v. 324, p. 01-08, 2021Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53856. Acesso em: 24 maio 2024.
APA
Ma, F., Darabi, M., Lhomme, M., Tubeuf, E., Canicio, A., Brerault, J., et al. (2021). Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, 324, 01-08. doi:10.1016/j.atherosclerosis.2021.03.002
NLM
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 maio 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Vancouver
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 maio 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Artigo de periodico
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels (2020)
Zheng, Kang H; Kaiser, Yannick; Olden, Casper C. van; Santos Filho, Raul Dias dos ; Dasseux, Jean-Louis; Genest, Jacques; Gaudet, Daniel; Westerink, Jan; Verberne, Hein J
Source: Atherosclerosis. Unidade: FM
Subjects: APOLIPOPROTEÍNAS, COLESTEROL, LIPOPROTEÍNAS HDL, MEIA IDADE, FOSFOLIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZHENG, Kang H et al. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, v. 311, p. 13-19, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.004. Acesso em: 24 maio 2024.
APA
Zheng, K. H., Kaiser, Y., Olden, C. C. van, Santos Filho, R. D. dos, Dasseux, J. -L., Genest, J., et al. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, 311, 13-19. doi:10.1016/j.atherosclerosis.2020.08.004
NLM
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004
Vancouver
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004
Artigo de periodico-carta/editorial
How and when to revascularize patients with chronic coronary syndrome [Editorial] (2020)
Cesar, Luiz Antonio Machado ; Mioto, Bruno Mahler
Source: International journal of cardiology. Unidade: FM
Subjects: INFARTO DO MIOCÁRDIO, ARTERIOSCLEROSE CORONÁRIA, PONTE DE ARTÉRIA CORONÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESAR, Luiz Antonio Machado e MIOTO, Bruno Mahler. How and when to revascularize patients with chronic coronary syndrome [Editorial]. International journal of cardiology. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.ijcard.2020.03.004. Acesso em: 24 maio 2024. , 2020
APA
Cesar, L. A. M., & Mioto, B. M. (2020). How and when to revascularize patients with chronic coronary syndrome [Editorial]. International journal of cardiology. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.ijcard.2020.03.004
NLM
Cesar LAM, Mioto BM. How and when to revascularize patients with chronic coronary syndrome [Editorial] [Internet]. International journal of cardiology. 2020 ; 308 26-27.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2020.03.004
Vancouver
Cesar LAM, Mioto BM. How and when to revascularize patients with chronic coronary syndrome [Editorial] [Internet]. International journal of cardiology. 2020 ; 308 26-27.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2020.03.004
Artigo de periodico
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries (2020)
Brieger, David; Pocockb, Stuart J; Blankenberg, Stefan; Chen, Ji Yan; Cohen, Mauricio G; Granger, Christopher B; Grieve, Richard; Nicolau, Jose Carlos ; Simon, Tabassome; Westermann, Dirk
Source: International journal of cardiology. Unidade: FM
Subjects: ENVELHECIMENTO, INFARTO DO MIOCÁRDIO, FATORES DE RISCO, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRIEGER, David et al. Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries. International journal of cardiology, v. 311, p. 7-14, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2020.01.070. Acesso em: 24 maio 2024.
APA
Brieger, D., Pocockb, S. J., Blankenberg, S., Chen, J. Y., Cohen, M. G., Granger, C. B., et al. (2020). Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries. International journal of cardiology, 311, 7-14. doi:10.1016/j.ijcard.2020.01.070
NLM
Brieger D, Pocockb SJ, Blankenberg S, Chen JY, Cohen MG, Granger CB, Grieve R, Nicolau JC, Simon T, Westermann D. Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries [Internet]. International journal of cardiology. 2020 ; 311 7-14.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2020.01.070
Vancouver
Brieger D, Pocockb SJ, Blankenberg S, Chen JY, Cohen MG, Granger CB, Grieve R, Nicolau JC, Simon T, Westermann D. Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries [Internet]. International journal of cardiology. 2020 ; 311 7-14.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2020.01.070
Artigo de periodico-carta/editorial
Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? (2020)
Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: ARTERIOSCLEROSE, CALCIFICAÇÃO FISIOLÓGICA, VASOS CORONÁRIOS, CORONARIOPATIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels?. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.12.019. Acesso em: 24 maio 2024. , 2020
APA
Santos Filho, R. D. dos. (2020). Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2019.12.019
NLM
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.12.019
Vancouver
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.12.019
Artigo de periodico
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia (2019)
Reeskamp, Laurens F; Kastelein, John J. P; Moriarty, Patrick M; Duell, P. Barton; Catapano, Alberico L; Santos Filho, Raul Dias dos; Ballantyne, Christie M
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, OLIGONUCLEOTÍDEOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REESKAMP, Laurens F et al. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 280, p. 109-117, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.11.017. Acesso em: 24 maio 2024.
APA
Reeskamp, L. F., Kastelein, J. J. P., Moriarty, P. M., Duell, P. B., Catapano, A. L., Santos Filho, R. D. dos, & Ballantyne, C. M. (2019). Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 280, 109-117. doi:10.1016/j.atherosclerosis.2018.11.017
NLM
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Vancouver
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Artigo de periodico
In memoriam: Dr. Akira Yamamoto 1932-2019 (2019)
Matsuzawa, Yuji; Yamashita, Shizuya; Santos Filho, Raul Dias dos; Libby, Peter
Source: Atherosclerosis. Unidade: FM
Subjects: ESTATINAS, BIOGRAFIAS, MEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATSUZAWA, Yuji et al. In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, v. 283, p. 120-120, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.01.028. Acesso em: 24 maio 2024.
APA
Matsuzawa, Y., Yamashita, S., Santos Filho, R. D. dos, & Libby, P. (2019). In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, 283, 120-120. doi:10.1016/j.atherosclerosis.2019.01.028
NLM
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.028
Vancouver
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.01.028
Artigo de periodico
Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial (2019)
Nicolau, José Carlos ; Stevens, Susanna R; Al-khalidi, Hussein R; Jatene, Fábio Biscegli ; Furtado, Remo H. M; Dallan, Luís Alberto Oliveira; Lisboa, Luiz A. F; Desvigne-nickens, Patrice; Haddad, Haissam; Jolicoeur, E. Marc
Source: International journal of cardiology. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, CIRURGIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NICOLAU, José Carlos et al. Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. International journal of cardiology, v. 291, p. 36-41, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2019.03.029. Acesso em: 24 maio 2024.
APA
Nicolau, J. C., Stevens, S. R., Al-khalidi, H. R., Jatene, F. B., Furtado, R. H. M., Dallan, L. A. O., et al. (2019). Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. International journal of cardiology, 291, 36-41. doi:10.1016/j.ijcard.2019.03.029
NLM
Nicolau JC, Stevens SR, Al-khalidi HR, Jatene FB, Furtado RHM, Dallan LAO, Lisboa LAF, Desvigne-nickens P, Haddad H, Jolicoeur EM. Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial [Internet]. International journal of cardiology. 2019 ; 291 36-41.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2019.03.029
Vancouver
Nicolau JC, Stevens SR, Al-khalidi HR, Jatene FB, Furtado RHM, Dallan LAO, Lisboa LAF, Desvigne-nickens P, Haddad H, Jolicoeur EM. Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial [Internet]. International journal of cardiology. 2019 ; 291 36-41.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2019.03.029
Artigo de periodico-carta/editorial
Baseline LDL-C levels and risk of cardiovascular events [Editorial]: is there any room for questions? (2019)
Rocha, Viviane Z; Santos Filho, Raul Dias dos
Source: International journal of cardiology. Unidade: FM
Subjects: LIPOPROTEÍNAS, LIPOPROTEÍNAS LDL, DOENÇAS CARDIOVASCULARES, METABOLISMO BASAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Viviane Z e SANTOS FILHO, Raul Dias dos. Baseline LDL-C levels and risk of cardiovascular events [Editorial]: is there any room for questions?. International journal of cardiology. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.ijcard.2019.03.058. Acesso em: 24 maio 2024. , 2019
APA
Rocha, V. Z., & Santos Filho, R. D. dos. (2019). Baseline LDL-C levels and risk of cardiovascular events [Editorial]: is there any room for questions? International journal of cardiology. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.ijcard.2019.03.058
NLM
Rocha VZ, Santos Filho RD dos. Baseline LDL-C levels and risk of cardiovascular events [Editorial]: is there any room for questions? [Internet]. International journal of cardiology. 2019 ; 286 166-167.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2019.03.058
Vancouver
Rocha VZ, Santos Filho RD dos. Baseline LDL-C levels and risk of cardiovascular events [Editorial]: is there any room for questions? [Internet]. International journal of cardiology. 2019 ; 286 166-167.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijcard.2019.03.058
Artigo de periodico
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia (2019)
Isla, Leopoldo Perez de; Ray, Kausik K.; Watts, Gerald F.; Santos Filho, Raul Dias dos ; Alonso, Rodrigo; Muniz-grijalvo, Ovidio; Diaz-diaz, Jose Luis; Badimon, Lina; Catapano, Alberico L; Mata, Pedro
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, AVALIAÇÃO DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISLA, Leopoldo Perez de et al. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 286, p. 40-45, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.05.003. Acesso em: 24 maio 2024.
APA
Isla, L. P. de, Ray, K. K., Watts, G. F., Santos Filho, R. D. dos, Alonso, R., Muniz-grijalvo, O., et al. (2019). Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, 286, 40-45. doi:10.1016/j.atherosclerosis.2019.05.003
NLM
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.05.003
Vancouver
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.05.003
Artigo de periodico
Dynamic cerebral autoregulation: a marker of post-operative delirium? (2019)
Caldas, Juliana R; Panerai, Ronney B; Bor-seng-shu, Edson; Ferreira, Graziela S. R; Camara, Ligia; Passos, R. H; De-lima-oliveira, Marcelo; Galas, Filomena R B G; Almeida, Juliano P; Nogueira, Ricardo C; Hajjar, Ludhmila Abrahão
Source: Clinical neurophysiology. Unidade: FM
Subjects: CÉREBRO, DELÍRIO, CIRCULAÇÃO EXTRACORPÓREA, REVASCULARIZAÇÃO MIOCÁRDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALDAS, Juliana R et al. Dynamic cerebral autoregulation: a marker of post-operative delirium?. Clinical neurophysiology, v. 130, n. 1, p. 101-108, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clinph.2018.11.008. Acesso em: 24 maio 2024.
APA
Caldas, J. R., Panerai, R. B., Bor-seng-shu, E., Ferreira, G. S. R., Camara, L., Passos, R. H., et al. (2019). Dynamic cerebral autoregulation: a marker of post-operative delirium? Clinical neurophysiology, 130( 1), 101-108. doi:10.1016/j.clinph.2018.11.008
NLM
Caldas JR, Panerai RB, Bor-seng-shu E, Ferreira GSR, Camara L, Passos RH, De-lima-oliveira M, Galas FRBG, Almeida JP, Nogueira RC, Hajjar LA. Dynamic cerebral autoregulation: a marker of post-operative delirium? [Internet]. Clinical neurophysiology. 2019 ; 130( 1): 101-108.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.clinph.2018.11.008
Vancouver
Caldas JR, Panerai RB, Bor-seng-shu E, Ferreira GSR, Camara L, Passos RH, De-lima-oliveira M, Galas FRBG, Almeida JP, Nogueira RC, Hajjar LA. Dynamic cerebral autoregulation: a marker of post-operative delirium? [Internet]. Clinical neurophysiology. 2019 ; 130( 1): 101-108.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.clinph.2018.11.008
Artigo de periodico
Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults (2018)
Fernandes, Romulo Araujo; Santos, Raul D
Source: Atherosclerosis. Unidade: FM
Subjects: ESTUDOS LONGITUDINAIS, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES, ÍNDICE DE MASSA CORPORAL, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Romulo Araujo e SANTOS, Raul D. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults. Atherosclerosis, v. 273, p. 131-135, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.02.011. Acesso em: 24 maio 2024.
APA
Fernandes, R. A., & Santos, R. D. (2018). Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults. Atherosclerosis, 273, 131-135. doi:10.1016/j.atherosclerosis.2018.02.011
NLM
Fernandes RA, Santos RD. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults [Internet]. Atherosclerosis. 2018 ; 273 131-135.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.02.011
Vancouver
Fernandes RA, Santos RD. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults [Internet]. Atherosclerosis. 2018 ; 273 131-135.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.02.011
Trabalho de evento-resumo periodico
Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions (2018)
Tavoni, Thauany Martins; Vinagre, Carmen Guilherme Christiano de Matos; Freitas, Fatima Rodrigues; Mesquita, Carlos Henrique de; Vinagre, Juliana Christiano de Matos; Mariani, A. C; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVONI, Thauany Martins et al. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 24 maio 2024. , 2018
APA
Tavoni, T. M., Vinagre, C. G. C. de M., Freitas, F. R., Mesquita, C. H. de, Vinagre, J. C. de M., Mariani, A. C., et al. (2018). Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 maio 24 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.[citado 2024 maio 24 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2018)
Meneghini, Bianca Correa; Tavares, Elaine Rufo; Guido, Maria Carolina; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca Correa et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf. Acesso em: 24 maio 2024. , 2018
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 maio 24 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.[citado 2024 maio 24 ] Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Artigo de periodico
Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice (2018)
Pang, Jing; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DIAGNÓSTICO PRECOCE, ACONSELHAMENTO, MODO DE VIDA, SUL-AFRICANOS, AUSTRALIANOS, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANG, Jing e SANTOS FILHO, Raul Dias dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice. Atherosclerosis, v. 277, p. 470-476, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.06.822. Acesso em: 24 maio 2024.
APA
Pang, J., & Santos Filho, R. D. dos. (2018). Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice. Atherosclerosis, 277, 470-476. doi:10.1016/j.atherosclerosis.2018.06.822
NLM
Pang J, Santos Filho RD dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice [Internet]. Atherosclerosis. 2018 ; 277 470-476.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.822
Vancouver
Pang J, Santos Filho RD dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice [Internet]. Atherosclerosis. 2018 ; 277 470-476.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.822
Artigo de periodico
Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil (2018)
Souto, Ana Cristina; Krieger, José Eduardo; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, QUALIDADE DE VIDA, TRIAGEM, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUTO, Ana Cristina e KRIEGER, José Eduardo e SANTOS FILHO, Raul Dias dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Atherosclerosis, v. 277, p. 464-469, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.05.036. Acesso em: 24 maio 2024.
APA
Souto, A. C., Krieger, J. E., & Santos Filho, R. D. dos. (2018). Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Atherosclerosis, 277, 464-469. doi:10.1016/j.atherosclerosis.2018.05.036
NLM
Souto AC, Krieger JE, Santos Filho RD dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil [Internet]. Atherosclerosis. 2018 ; 277 464-469.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.05.036
Vancouver
Souto AC, Krieger JE, Santos Filho RD dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil [Internet]. Atherosclerosis. 2018 ; 277 464-469.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.05.036
Artigo de periodico
Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil (2018)
Harada, Paulo H; Bensenor, Isabela M; Santos Filho, Raul Dias; Lotufo, Paulo Andrade; Miname, Márcio H
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, PREVALÊNCIA, ESTUDOS LONGITUDINAIS, GRUPOS ÉTNICOS, FATORES SEXUAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARADA, Paulo H et al. Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil. Atherosclerosis, v. 277, p. 273-277, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.08.021. Acesso em: 24 maio 2024.
APA
Harada, P. H., Bensenor, I. M., Santos Filho, R. D., Lotufo, P. A., & Miname, M. H. (2018). Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil. Atherosclerosis, 277, 273-277. doi:10.1016/j.atherosclerosis.2018.08.021
NLM
Harada PH, Bensenor IM, Santos Filho RD, Lotufo PA, Miname MH. Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil [Internet]. Atherosclerosis. 2018 ; 277 273-277.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.021
Vancouver
Harada PH, Bensenor IM, Santos Filho RD, Lotufo PA, Miname MH. Familial hypercholesterolemia prevalence in an admixed racial society: sex and race matter. The ELSA-Brasil [Internet]. Atherosclerosis. 2018 ; 277 273-277.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.021
Artigo de periodico
Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia (2018)
Hagger, Martin S; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, ADESÃO À MEDICAÇÃO, SENSO COMUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAGGER, Martin S e SANTOS FILHO, Raul Dias dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis, v. 277, p. 493-501, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.06.010. Acesso em: 24 maio 2024.
APA
Hagger, M. S., & Santos Filho, R. D. dos. (2018). Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia. Atherosclerosis, 277, 493-501. doi:10.1016/j.atherosclerosis.2018.06.010
NLM
Hagger MS, Santos Filho RD dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia [Internet]. Atherosclerosis. 2018 ; 277 493-501.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.010
Vancouver
Hagger MS, Santos Filho RD dos. Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia [Internet]. Atherosclerosis. 2018 ; 277 493-501.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.06.010

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation